Drosophila models of pathogenic copy-number variant genes show global and non-neuronal defects during development
Authors:
Tanzeen Yusuff aff001; Matthew Jensen aff001; Sneha Yennawar aff001; Lucilla Pizzo aff001; Siddharth Karthikeyan aff001; Dagny J. Gould aff001; Avik Sarker aff001; Erika Gedvilaite aff001; Yurika Matsui aff001; Janani Iyer aff001; Zhi-Chun Lai aff001; Santhosh Girirajan aff001
Authors place of work:
Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America
aff001; Department of Biology, Pennsylvania State University, University Park, Pennsylvania, United States of America
aff002; Department of Anthropology, Pennsylvania State University, University Park, Pennsylvania, United States of America
aff003
Published in the journal:
Drosophila models of pathogenic copy-number variant genes show global and non-neuronal defects during development. PLoS Genet 16(6): e32767. doi:10.1371/journal.pgen.1008792
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1008792
Summary
While rare pathogenic copy-number variants (CNVs) are associated with both neuronal and non-neuronal phenotypes, functional studies evaluating these regions have focused on the molecular basis of neuronal defects. We report a systematic functional analysis of non-neuronal defects for homologs of 59 genes within ten pathogenic CNVs and 20 neurodevelopmental genes in Drosophila melanogaster. Using wing-specific knockdown of 136 RNA interference lines, we identified qualitative and quantitative phenotypes in 72/79 homologs, including 21 lines with severe wing defects and six lines with lethality. In fact, we found that 10/31 homologs of CNV genes also showed complete or partial lethality at larval or pupal stages with ubiquitous knockdown. Comparisons between eye and wing-specific knockdown of 37/45 homologs showed both neuronal and non-neuronal defects, but with no correlation in the severity of defects. We further observed disruptions in cell proliferation and apoptosis in larval wing discs for 23/27 homologs, and altered Wnt, Hedgehog and Notch signaling for 9/14 homologs, including AATF/Aatf, PPP4C/Pp4-19C, and KIF11/Klp61F. These findings were further supported by tissue-specific differences in expression patterns of human CNV genes, as well as connectivity of CNV genes to signaling pathway genes in brain, heart and kidney-specific networks. Our findings suggest that multiple genes within each CNV differentially affect both global and tissue-specific developmental processes within conserved pathways, and that their roles are not restricted to neuronal functions.
Keywords:
Drosophila melanogaster – Genetic networks – Phenotypes – RNA interference – apoptosis – Eyes – Notch signaling – Hedgehog signaling
Introduction
Rare copy-number variants (CNVs), or deletions and duplications in the genome, are associated with neurodevelopmental disorders such as autism, intellectual disability (ID), and schizophrenia [1,2]. While dosage alteration of CNV regions contribute predominantly to defects in nervous system development, several CNV-associated disorders also lead to early developmental features involving other organ systems [3,4], including cardiac defects [5,6], kidney malformations [7], craniofacial features [3], and skeletal abnormalities [8]. In fact, an overall survey of ten rare disease-associated CNVs among individuals within the DECIPHER database [9] showed a wide range of non-neuronal phenotypes across multiple organ systems for each CNV disorder (S1 Fig, S1 Data). For example, the 1q21.1 deletion causes variable expression of multiple neuronal and non-neuronal phenotypes, including developmental delay, autism, and schizophrenia as well as craniofacial features, cataracts, cardiac defects, and skeletal abnormalities [10–12]. Additionally, while the 7q11.23 deletion associated with Williams-Beuren syndrome (WBS) causes neuropsychiatric and behavioral features, other non-neuronal phenotypes, including supravalvular aortic stenosis, auditory defects, hypertension, diabetes mellitus, and musculoskeletal and connective tissue anomalies, are also observed among the deletion carriers [13].
Despite the prevalence of non-neuronal phenotypes among CNV carriers, functional studies of CNV genes have primarily focused on detailed assessments of neuronal and behavioral phenotypes in model systems. For example, mouse models for the 16p11.2 deletion exhibited post-natal lethality, reduced brain size and neural progenitor cell count, motor and habituation defects, synaptic defects, and behavioral defects [14–16]. Similarly, mouse models for the 3q29 deletion showed decreased weight and brain size, increased locomotor activity, increased startle response, and decreased spatial learning and memory [17,18]. However, fewer studies have focused on detailed evaluation of non-neuronal phenotypes in functional models of CNV disorders. For example, Arbogast and colleagues evaluated obesity and metabolic changes in 16p11.2 deletion mice, which showed reduced weight and impaired adipogenesis [19]. While Haller and colleagues showed that mice with knockdown of MAZ, a gene within the 16p11.2 deletion region, exhibit genitourinary defects also observed in individuals with the deletion [20], mouse studies for other homologs of 16p11.2 genes, including TAOK2, KCTD13, and MAPK3, have only focused on assessing neuronal defects [21–25]. Furthermore, Dickinson and colleagues reported a high-throughput analysis of essential genes in mice and identified both neuronal and non-neuronal phenotypes for individual gene knockouts, including more than 400 genes that lead to lethality [26]. While these efforts aided in implicating novel genes with human disease, our understanding of how genes associated with neurodevelopmental disorders contribute towards non-neuronal phenotypes is still limited. Therefore, a large-scale analysis of non-neuronal phenotypes is necessary to identify specific candidate genes within CNV regions and associated biological mechanisms that contribute towards these phenotypes.
Drosophila melanogaster is an excellent model system to evaluate homologs of neurodevelopmental genes, as many developmental processes and signaling pathways are conserved between humans and flies [27]. In fact, over 75% of human disease genes have homologs in Drosophila, including many genes involved in cellular signaling processes [28,29]. We recently examined the contributions of individual Drosophila homologs of 28 genes within the 16p11.2 and 3q29 deletion regions towards specific neurodevelopmental phenotypes, including rough eye phenotypes and defects in climbing ability, axon targeting, neuromuscular junction, and dendritic arborization [30,31]. While these findings implicated multiple genes within each CNV region towards conserved cellular processes in neuronal tissues, the conserved role of these genes in non-neuronal tissues is not well understood. The Drosophila wing is an effective model system to evaluate such developmental defects, as key components of conserved signaling pathways, such as Notch, epidermal growth factor receptor (EGFR), Hegdehog, and Wnt pathways, were identified using fly wing models [32–38]. Although fly wing phenotypes cannot be directly translated to human phenotypes, defects observed in fly wings can be used to assess how homologs of human disease genes alter conserved cellular and developmental mechanisms. For example, Wu and colleagues showed that overexpression of the Drosophila homolog for UBE3A, associated with Angelman syndrome, leads to abnormal wing and eye morphology defects [39]. Furthermore, Drosophila mutant screens for developmental phenotypes, including wing defects, were used to identify conserved genes for several human genetic diseases, including Charcot-Marie-Tooth disease and syndromic microcephaly [40]. Kochinke and colleagues also recently performed a large-scale screening of ID-associated genes, and found an enrichment of wing trichome density and missing vein phenotypes in ID genes compared to control gene sets [41]. Hence, the fly wing provides a model system that is ideal for evaluating the contributions of individual homologs of CNV genes towards cellular and developmental defects.
In this study, we tested tissue-specific and cellular phenotypes of 79 total fly homologs, including 59 fly homologs of human genes within ten pathogenic CNV regions and 20 genes associated with neurodevelopmental disorders. We used the adult fly wing to evaluate phenotypes in a non-neuronal tissue, and observed a wide range of robust qualitative and quantitative wing phenotypes among 136 RNA interference (RNAi) lines, including size defects, ectopic and missing veins, severe wrinkling, and lethality. Further analysis of cellular phenotypes revealed disruptions in conserved developmental processes in the larval imaginal wing disc, including altered levels of cell proliferation and apoptosis as well as altered expression patterns in the Wnt, Hedgehog, and Notch signaling pathways. However, we found no correlation in the severity of phenotypes observed with wing and eye-specific knockdown. These findings were further supported by differences in expression patterns and network connectivity of human CNV genes across different tissues. Our analysis emphasizes the importance of multiple genes within each CNV region towards both global and tissue-specific developmental processes.
Results
Knockdown of fly homologs of CNV genes contribute to a range of wing defects
We used the bxMS1096-GAL4 wing-specific driver to assess a total of 136 RNAi lines for 59 fly homologs of 130 total human genes within pathogenic CNV regions (chromosomal locations 1q21.1, 3q29, 7q11.23, 15q11.2, 15q13.3, 16p11.2, distal 16p11.2, 16p12.1, 16p13.11, and 17q12), as well as 20 fly homologs of human genes associated with neurodevelopmental disorders (S2 Data). Fly homologs of these genes were identified using the DIOPT orthology prediction tool (S2 Data) [42]. We list both the human gene name and the fly gene name for each tested gene as HUMAN GENE/Fly gene (i.e. KCTD13/CG10465), as well as the human CNV region for context at first instance. We scored 20–25 adult wings for five distinct wing phenotypes in each non-lethal RNAi line, including wrinkled wing, discoloration, ectopic veins, missing veins, and bristle planar polarity phenotypes (Fig 1; S3 Data). We categorized adult female wing phenotypes based on their severity, and performed k-means clustering analysis to categorize each RNAi line by their overall phenotypic severity (Fig 2A and 2B). We observed four clusters of RNAi lines: 75 lines with no observable qualitative phenotypes (55.2%), 24 lines with mild phenotypes (17.6%), 10 lines with moderate phenotypes (7.4%), 21 lines with severe phenotypes (15.4%), and 6 lines with lethal phenotypes (4.4%), including ACACA/ACC within 17q12, DLG1/dlg1 within 3q29, and STX1A/Syx1A within 7q11.23 (Fig 2; S3 Data). We observed severe wrinkled wing phenotypes for 13/79 fly homologs, including PPP4C/Pp4-19C within 16p11.2, ATXN2L/Atx2 within distal 16p11.2, AATF/Aatf within 17q12, and MFI2/Tsf2 within 3q29 (Fig 3A and 3B, S4 Data). Interestingly, seven out of ten CNV regions contained at least one homolog that showed lethality or severe wing phenotype, and five CNV regions (3q29, 16p11.2, distal 16p11.2, 16p12.1, and 17q12) had multiple homologs showing lethality or severe wing phenotypes (Fig 3A, S4 Data). For example, RNAi lines for both UQCRC2/UQCR-C2 and POLR3E/Sin within 16p12.1 showed lethality. Within the 3q29 region, NCBP2/Cbp20 and MFI2/Tsf2 showed severe phenotypes, while DLG1/dlg1 showed lethality. In contrast, 12/20 known neurodevelopmental genes showed no observable wing phenotypes, suggesting that these genes could be responsible for neuronal-specific phenotypes (Fig 3B, S4 Data). We note that 18/79 fly homologs showed discordant phenotypes between two or more RNAi lines for the same gene, which could be due to differences in expression of the RNAi construct among these lines (S4 Data).
Certain qualitative phenotypes were present at a higher frequency in males compared to females among all non-lethal and non-severe RNAi lines (independent of k-means clustering analysis). For example, discoloration (87 lines in males compared to 55 lines in females; p = 1.315×10−4, two-tailed Fisher’s exact test) and missing vein phenotypes (92 lines in males compared to 29 lines in females; p = 2.848×10−16, two-tailed Fisher’s exact test) were more commonly observed in males than females (S3 Data). In particular, 25/92 lines in males (compared to 1/29 lines in females) showed a total loss of the anterior crossvein (ACV) (S3 Data). We further identified 17 RNAi lines that were lethal in males with wing-specific knockdown of fly homologs. While higher frequencies of wing phenotypes in males could be due to a sex-specific bias of developmental phenotypes, the increased severity we observed in males is most likely due to a stronger RNAi knockdown caused by X-linked dosage compensation, as the bxMS1096-GAL4 driver is inserted on the fly X chromosome [43,44].
Next, we measured the total adult wing area and lengths of six veins (longitudinal L2, L3, L4, L5, ACV, and posterior crossvein or PCV) in the adult wing for each of the tested RNAi lines that did not show lethality (or severe wrinkled phenotypes for vein length measurements) (Fig 4A). Overall, we identified significant wing measurement changes for 89 RNAi lines compared to controls, which included lines that did not have an observable qualitative wing phenotype (Fig 2C, S3 Data). A summary of L3 vein lengths is presented in Fig 4B, and the measurements for the remaining five veins are provided in S2 Fig and S3 Data. We found that 33/61 homologs (54.1%) showed significant changes in L3 vein length, including 20 homologs with longer vein lengths and 13 homologs with shorter vein lengths (S4 Data). Additionally, 41/74 fly homologs (55.4%) showed changes in wing area, including 36 homologs which showed smaller wing areas and five homologs showed larger wing areas compared to controls (S4 Data). For example, both homologs of genes within 1q21.1 region, BCL9/lgs and FMO5/Fmo-2, showed decreased wing area and vein length, potentially mirroring the reduced body length phenotype observed in mouse models of the deletion [45] (Fig 4B and 4C). In addition, PAK2/Pak within 3q29, TBX1/org-1 within 22q11.2, autism-associated CHD8/kis, and microcephaly-associated ASPM/asp also showed smaller wing areas and vein lengths (Fig 4B and 4C). In contrast, TRPM1/Trpm within 15q13.3 and the cell proliferation gene PTEN/Pten [46] both showed larger wing areas and vein lengths (Fig 4B and 4C). Furthermore, we identified eight homologs that showed no qualitative wing phenotypes, but had significant changes in wing areas and vein lengths, including CCDC101/Sgf29 in distal 16p11.2, FMO5/Fmo-2, TRPM1/Trpm, DHRS11/CG9150 in 17q12, and NSUN5/Nsun5 in 7q11.23 (Fig 4B and 4C; S4 Data). These results indicate that homologs of certain CNV genes may influence variations in size without causing adverse wing phenotypes, and may be specifically implicated towards cellular growth mechanisms.
Homologs of CNV genes show global and tissue-specific effects during development
We previously showed that many fly homologs of CNV genes that showed wing defects in the current study also contributed towards neuronal phenotypes in the fly eye [30,31], suggesting a role for these genes in global development. We therefore performed ubiquitous and eye-specific knockdown of fly homologs to assess tissue-specific effects in comparison to the wing phenotypes. First, we used the da-GAL4 driver at 25°C to drive ubiquitous knockdown of RNAi lines for 31 homologs of CNV genes, including 19 that were previously published [30,31]. We observed complete or partial lethality at larval and pupal stages with knockdown of 10/31 homologs (32.3%) (Fig 5A). Lethal phenotypes have also been documented for 43/130 knockout mouse models of individual CNV genes as well as for entire deletion regions (S5 Data). For example, mouse models heterozygous for the 16p11.2 deletion showed partial neonatal lethality, while knockout mouse models of four individual homologs of genes within the 16p11.2 region, including Ppp4C-/- and Kif22-/-, showed embryonic lethality [14,47,48]. In our study, the DLG1/dlg1 line that showed lethality with wing-specific knockdown also exhibited larval lethality with ubiquitous knockdown, indicating its role in global development (Fig 5A). In addition, six homologs that showed severe wing phenotypes also showed larval or pupal lethality with ubiquitous knockdown, including ALDOA/Ald and PPP4C/Pp4-19C within 16p11.2 and ATXN2L/Atx2 and TUFM/mEFTu1 within distal 16p11.2 (Fig 5A). The remaining homologs that showed lethality with ubiquitous knockdown showed at least a mild qualitative or quantitative wing phenotype.
We next compared the phenotypes observed with wing-specific knockdown of fly homologs to their corresponding eye-specific knockdowns to evaluate tissue-specific effects. The Drosophila eye has been classically used to evaluate neuronal phenotypes due to genetic perturbations, as individual ommatidial units within the eye contain photoreceptor neurons that project into the optic lobe within the brain [49,50]. In fact, numerous genes associated with human neurological disorders have been modeled using the fly eye [51–53]. To quantitatively assess the phenotypic severity of cellular defects with eye-specific knockdown of fly homologs, we developed a computational tool called Flynotyper [54] that quantifies the degree of disorganization among the ommatidia in the adult eye. We analyzed phenotypic scores obtained from Flynotyper for 66 RNAi lines of 45 fly homologs, including from previously published datasets [30,31,54]. We found that 37/45 homologs (82.2%) exhibited both eye and wing-specific defects (Fig 5B, S3 Fig, S6 Data). Two homologs with significant eye phenotypes did not show any wing phenotypes, including SPNS1/spin within distal 16p11.2 and microcephaly-associated SLC25A19/Tpc1 [55], while five homologs only showed wing-specific phenotypes, including CDIPT/Pis and YPEL3/CG15309 within 16p11.2, FBXO45/Fsn and OSTalpha/CG6836 within 3q29, and UQCRC2/UQCR-C2 (Fig 5B, S3 Fig). In particular, UQCRC2/UQCR-C2 showed lethality with wing-specific knockdown, suggesting potential tissue-specific effects of this gene in non-neuronal cells (Fig 5B). While most homologs contributed towards both eye and wing-specific phenotypes, we observed a wide range of severity in eye phenotypes that did not correlate with the severity of quantitative or qualitative wing phenotypes (Fig 5C). For example, TUFM/mEFTu1 showed a severe wing phenotype but only a mild increase in eye phenotypic score, while SH2B1/Lnk, also within the distal 16p11.2 region, showed severe rough eye phenotypes but only a mild increase in wing size (Fig 5D). Similarly, BCL9/lgs also showed opposing tissue-specific effects with mild qualitative wing phenotypes and severe eye phenotypes, suggesting that the role of these homologs towards development differs across tissue types.
CNV genes show variable expression across different tissues in flies and humans
To assess how expression levels of CNV genes vary across different tissues, we first examined the expression patterns of fly homologs in larval and adult tissues using the FlyAtlas Anatomical Microarray dataset [56]. We found that 76/77 homologs with available data were expressed in at least one larval and adult tissue (S4 Fig, S7 Data). In general, we did not observe a correlation between wing phenotype severity and expression patterns of homologs in larval or adult tissues (Fig 6A). For example, 58/77 homologs (75.3%) showed ubiquitous larval expression, including both fly homologs that showed no qualitative wing phenotypes, such as KCTD13/CG10465 within 16p11.2 and FBXO45/Fsn, and those with severe wing phenotypes, such as PPP4C/Pp4-19C and NCBP2/Cbp20 (Fig 6A, S4 Fig). Furthermore, 30/39 homologs (76.9%) that showed eye phenotypes also had ubiquitous larval expression, providing further support to the observation that genes causing neuronal phenotypes may also contribute to developmental phenotypes in other tissues (S6 Data). Of note, 9/77 homologs (11.7%) did not have any expression in the larval central nervous system (CNS), including FMO5/Fmo-2, BDH1/CG8888 within 3q29, and TBX6/Doc2 within 16p11.2 (Fig 6A, S4 Fig). However, we observed wing phenotypes for 8/9 of these homologs, suggesting that they may contribute to tissue-specific phenotypes outside of the nervous system. Except for the epilepsy-associated SCN1A/para [57], which was exclusively expressed in both the larval central nervous system (CNS) and adult brain tissues, the other tested neurodevelopmental genes were also expressed in non-neuronal tissues (Fig 6A).
We further used the GTEx Consortium dataset [58] to examine tissue-specific expression of 130 human CNV genes and 20 known neurodevelopmental genes across six tissues including brain, heart, kidney, lung, liver, and muscle. We found 121/150 genes (80.7%) that were expressed in at least one adult tissue, including 49/150 genes (32.7%) that showed ubiquitous expression across all six tissues (S6 Data). Furthermore, 112/150 genes (74.7%) were expressed in non-neuronal tissues, including 34/150 (22.7%) genes without any neuronal expression, such as TBX1, FMO5 and GJA5 within 1q21.1, and ATP2A1 within distal 16p11.2 (Fig 6B, S7 Data). FMO5 and TBX1 also showed non-neuronal expression in Drosophila tissues, suggesting that their tissue-specific expression is highly conserved (Fig 6A). Other genes with ubiquitous expression also showed preferentially higher expression within specific non-neuronal tissues, including ALDOA and UQCRC2 for muscle and heart (Fig 6B). In contrast, we found nine genes that were expressed only in the adult brain, including FAM57B and DOC2A within 16p11.2, as well as SCN1A, which showed similar CNS-only expression in Drosophila tissues (Fig 6B, S7 Data).
Knockdown of fly homologs of CNV genes lead to disruption of cellular processes
Disruptions of basic cellular processes in neuronal cells, such as cell proliferation and apoptosis, have been implicated in neurodevelopmental disorders [59–61]. We previously identified defects in cell proliferation among photoreceptor neurons in larval eye discs with knockdown of 16p11.2 homologs, as well as increased apoptosis with knockdown of a subset of 3q29 homologs [30,31]. Here, we explored how these basic cellular processes are altered in non-neuronal cells, specifically in the developing wing disc, with knockdown of homologs of CNV genes. We targeted 27 fly homologs that showed a range of adult wing phenotypes for changes in cell proliferation and apoptosis, using immunostaining for anti-phospho-Histone H3 Ser10 (pH3) and anti-Drosophila caspase-1 (dcp1), respectively, in the third instar larval wing discs. We identified 23/27 homologs that showed significant increases in apoptotic cells compared to controls, including seven homologs, such as PPP4C/Pp4-19C, ATXN2L/Atx2, and AATF/Aatf, which showed dcp1 staining across the entire larval wing pouch (Fig 7A and 7B, S5 and S6 Figs, S8 Data). In addition, 16/27 homologs showed decreased levels of proliferation, including eight homologs which also showed apoptosis defects, such as CYFIP1/Sra-1 within 15q11.2, SH2B1/Lnk, and the microcephaly gene KIF11/Klp61F (Fig 7A and 7C, S5 and S6 Figs, S8 Data). All six of the tested homologs with severe adult wing phenotypes showed both increased apoptosis and decreased proliferation (S8 Data). Similarly, 3/4 homologs showing lethality with wing-specific knockdown also showed defects in apoptosis or proliferation, with the exception of ACACA/ACC (S5 Fig, S8 Data). As bxMS1096-GAL4 is located on the X-chromosome, we expected to see more severe defects in males compared with females due to X-linked dosage compensation [43,44]. However, knockdown of 3/11 tested homologs with sex-specific differences in adult wing phenotypes, including BCL9/lgs, CYFIP1/Sra-1, and DNAJC30/CG11035 within 7q11.23, showed significantly decreased levels of cell proliferation in females but no changes in males compared to their respective controls, suggesting sex-specific effects of these genes towards cell proliferation (S6 Fig, S8 Data). Overall, our results suggest that cell proliferation and apoptosis are disrupted by reduced expression of homologs of CNV genes in both neuronal and non-neuronal tissues.
Knockdown of homologs of CNV genes disrupt conserved signaling pathways
Several conserved signaling pathways that are active in a spatial and temporal manner in the larval wing disc, such as Wnt, Hedgehog, BMP, and Notch signaling, regulate the anterior-posterior (A/P) and dorsal-ventral (D/V) boundaries to determine accurate morphology and vein patterning in the adult wing [37,38,62–64]. For example, Wnt and Notch signaling pathways act along the D/V boundary to determine cell fate [65,66], while Hedgehog signaling is dependent upon expression of both engrailed in the posterior compartment and patched along the A/P border [67,68]. Moreover, O’Roak and colleagues showed that genes carrying de novo mutations in patients with autism are linked to β-catenin/Wnt pathway [69]. In addition, familial loss-of-function mutations in the human Hedgehog signaling pathway gene PTCH1 have been implicated in basal cell nevus syndrome, which leads to basal cell carcinoma [70,71].
Based on adult wing phenotypes and disruptions to cellular processes, we next tested whether knockdown of 14 fly homologs disrupt conserved signaling pathways in the third instar larval wing disc (S8 Data). In particular, we evaluated the role of Wnt, Hedgehog, and Notch signaling pathways by testing the expression patterns of four key proteins within these pathways, including wingless (Wnt), patched (Hedgehog), engrailed (Hedgehog), and delta (Notch). We found that 9/14 homologs, including 8/10 homologs showing severe wing phenotypes or lethality, exhibited disruptions in at least one signaling pathway (S8 Data). For example, five homologs with severe or lethal phenotypes showed disruptions of all four signaling pathways, including AATF/Aatf, NCBP2/Cbp20, POLR3E/Sin, PPP4C/Pp4-19C, and KIF11/Klp61F (Fig 8, S8 Data). Our observations are in concordance with previous findings by Swarup and colleagues, who showed that PPP4C/Pp4-19C is a candidate regulator of Wnt and Notch signaling pathways in Drosophila larval wing discs [72]. Furthermore, two genes from the 3q29 region, DLG1/dlg1 and MFI2/Tsf2, showed altered expression patterns for delta and patched but not for engrailed, indicating that they selectively interact with the Hedgehog as well as Notch signaling pathways (S7 Fig). In fact, Six and colleagues showed that Dlg1 directly binds to the PDZ-binding domain of Delta1 [73]. In contrast, ACACA/ACC and UQCRC2/UQCR-C2 showed no changes in expression patterns for any of the four signaling proteins tested, suggesting that the observed lethality could be due to other cellular mechanisms (S7 Fig). We conclude that several tested homologs disrupt the expression of key proteins in signaling pathways in the developing larval wing discs, potentially accounting for the developmental defects observed in the adult wings.
Connectivity patterns of CNV genes vary across human tissue-specific networks
We examined patterns of connectivity for nine candidate genes, based on disruptions of signaling pathways identified in developing Drosophila wing discs, within the context of human brain, heart, and kidney-specific gene interaction networks [74]. These tissue-specific networks were constructed using Bayesian classifier-generated probabilities for pairwise genetic interactions based on co-expression data [74]. Within each network, we calculated the lengths of the shortest paths between each candidate gene and 267 genes from the Wnt, Notch, and Hedgehog pathways as a proxy for connectivity (S9 Data). In all three networks, each of the candidate genes were connected to a majority of the signaling pathway genes (Fig 9A, S8 Fig). Interestingly, we observed a higher connectivity (i.e. shorter path distances) between candidate genes and Wnt and Hedgehog pathway genes in the brain-specific network compared to the heart and kidney-specific networks (Fig 9B). We further identified enrichments for genes involved in specific biological processes among the connector genes that were located in the shortest paths within neuronal and non-neuronal tissue-specific networks (Fig 9C, S9 Data). For example, axon-dendrite transport, dopaminergic signaling, and signal transduction functions were enriched among connector genes only for the brain-specific network, while organelle organization and protein ubiquitination were enriched among connector genes only for kidney and heart networks (Fig 9C). However, several core biological processes, such as cell cycle, protein metabolism, transcriptional regulation, and RNA processing/splicing, were enriched among connector genes within all three tissue-specific networks (Fig 9C). Our analysis highlights that human CNV genes potentially interact with developmental signaling pathways in a ubiquitous manner, but may affect different biological processes in neuronal and non-neuronal tissues.
Discussion
We used the Drosophila wing as a model to assess how homologs of key CNV genes contribute towards non-neuronal phenotypes. We tested fly homologs of 79 genes and identified multiple homologs within each CNV region that exhibited robust phenotypes indicative of developmental disruptions. Several themes have emerged from our study highlighting the importance of fly homologs of CNV genes towards both global and tissue-specific phenotypes.
First, we found that fly homologs of CNV genes contribute towards developmental phenotypes through ubiquitous roles in neuronal and non-neuronal tissues. Although we did not study models for the entire CNV, nearly all individual fly homologs of CNV genes contribute to wing-specific developmental defects. It is likely that these genes also contribute to additional phenotypes in other tissues that we did not assess. In fact, a subset of these homologs also showed early lethality with ubiquitous knockdown in addition to severe or lethal wing-specific phenotypes. However, we found no correlation between the severity of the eye and wing phenotypes, suggesting tissue-specific effects of these homologs towards developmental defects. In contrast, fly homologs of known neurodevelopmental genes generally showed milder wing phenotypes compared with eye phenotypes, indicating a more neuronal role for these genes. While our study only examined a subset of CNV genes with Drosophila homologs, phenotypic data from knockout mouse models also support a global developmental role for individual CNV genes. In fact, 44/130 (33.8%) knockout models of CNV genes within the Mouse Genome Informatics (MGI) database [75] exhibited non-neuronal phenotypes, including 20 homologs of CNV genes that showed both neuronal and non-neuronal phenotypes (S5 Data). For example, knockout mouse models of Dlg1-/- showed defects in dendritic growth and branching in the developing nervous system, in addition to craniofacial features and multiple kidney and urinary tract defects [76–79]. Furthermore, Chapman and colleagues showed that knockout of Tbx6-/- caused defects in mesodermal and neuronal differentiation early in development, leading to abnormal vascular, tail bud, and neural tube morphology [80]. These observations further support our findings that most fly homologs of CNV genes have a global role in development that could account for the observed non-neuronal defects.
Second, based on tissue-specific phenotypes, we identified fly homologs of CNV genes that are key regulators of conserved cellular processes important for development. For example, 9/10 homologs with severe or lethal adult wing phenotypes also exhibited defects in cell proliferation and apoptosis during development. In fact, we found concordance between cellular processes affected by wing and eye-specific knockdown of homologs of genes within 16p11.2 and 3q29 regions, including decreased proliferation for MAPK3/rl and increased apoptosis for NCBP2/Cbp20 and DLG1/dlg1 [30,31]. While eye-specific knockdown of BDH1/CG8888 showed decreased cell proliferation in larval eye discs [31], we found increased cell proliferation with wing-specific knockdown, suggesting a tissue-specific effect for this gene. Notably, at least one fly homolog per CNV region showed defects in cell proliferation or apoptosis, suggesting these cellular processes are important for development in both neuronal and non-neuronal tissues. For example, ATXN2L/Atx2, SH2B1/Lnk, and CCDC101/Sgf29 each showed decreased proliferation and increased apoptosis, suggesting a potential shared cellular mechanism for several genes within the distal 16p11.2 deletion. Furthermore, a subset of these genes also disrupted multiple signaling pathways, indicating a potential role for these homologs as key regulators of developmental processes. We specifically identified five homologs whose knockdown caused disruptions of Wnt, Notch, and Hedgehog signaling pathways. Each of these genes have important roles in cell cycle regulation, apoptosis, transcription, or RNA processing, based on Gene Ontology annotations [81,82]. In fact, we found that the RNA transport protein NCBP2/Cbp20 [83], which we recently identified as a key modifier gene for the 3q29 deletion [31], interfaced with all three signaling pathways. Furthermore, AATF disrupts apoptosis and promotes cell cycle progression through displacement of HDAC1 [84–86], while PPP4C promotes spindle organization at the centromeres during mitosis [87]. While we only evaluated the role of these genes towards development in a single fly tissue, our additional analysis of human gene interaction networks showed strong connectivity between the CNV genes and signaling pathways in multiple neuronal and non-neuronal human tissues. In fact, cell cycle genes were enriched among the connector genes in all three tested tissue-specific networks, further emphasizing the role of cell cycle processes towards developmental phenotypes. Notably, we also observed certain biological processes enriched among connector genes that were specific to neuronal or non-neuronal tissues, indicating that genes within CNV regions may affect different biological processes in a tissue-specific manner.
Overall, we show that fly homologs of most CNV genes contribute towards global developmental phenotypes, although exactly how they contribute toward such phenotypes varies between neuronal and non-neuronal tissues. Previous functional studies for CNV disorders have focused primarily on identifying candidate genes for the observed neuronal phenotypes. In this study, we identified several homologs of CNV genes that are responsible for non-neuronal defects, as well as novel associations between these homologs and conserved biological processes and pathways. We therefore propose that multiple genes within each CNV region differentially disrupt conserved cellular pathways and biological processes in neuronal versus non-neuronal tissues during development (Fig 10). These results are in line with a multigenic model for CNV disorders, as opposed to models where individual causative genes are responsible for specific phenotypes [30,31,88]. Our study further exemplifies the utility of evaluating non-neuronal phenotypes in addition to neuronal phenotypes in functional models of individual genes and CNV regions associated with developmental disorders, including future studies in mammalian or cellular model systems. Further studies exploring how CNV genes interact with each other and with other developmental pathways could more fully explain the conserved mechanisms underlying global developmental defects and identify potential therapeutic targets for these disorders.
Materials and methods
Fly stocks and genetics
We selected Drosophila homologs for 59 human genes out of 130 total genes located within 10 pathogenic CNV regions [89] associated with neurodevelopmental disorders (1q21.1, 3q29, 7q11.23, 15q11.2, 15q13.3, 16p11.2, distal 16p11.2, 16p12.1, 16p13.11, and 17q12) (S2 Data). These 59 genes were selected based on the presence of fly homologs, availability of RNAi lines, and quality control of the RNAi lines. In addition, we evaluated fly homologs of 20 human genes known to be in involved in neurodevelopmental disorders [54,90] (S2 Data). These include genes involved in the β-catenin signaling pathway (5 genes), core genes implicated in neurodevelopmental disorders (8 genes), and genes associated with microcephaly (7 genes) [91]. We note that 2/20 neurodevelopmental genes, TBX1 (22q11.2 deletion) [92] and UBE3A (Prader-Willi/Angelman syndrome region) [93], are located within other pathogenic CNV regions. We used the DRSC Integrative Ortholog Prediction Tool (DIOPT, v.7.1) [42] to select fly homologs for each human gene based on highest numeric score, excluding genes with “low” rankings (score <2) (S2 Data).
To knockdown individual genes in specific tissues, we used RNA interference (RNAi) and the UAS-GAL4 system (Fig 1), a well-established tool that allows for tissue-specific expression of a gene of interest [94]. RNAi lines were obtained from Vienna Drosophila Resource Center (VDRC), including both GD and KK lines. We tested a total of 136 lines in our data analysis (S10 Data). A complete list of stock numbers and full genotypes for all RNAi lines used in this study is presented in S10 Data. We used the bxMS1096-GAL4/FM7c;;UAS-Dicer2/TM6B driver for wing-specific knockdown and w1118;GMR-GAL4;UAS-Dicer2 driver (Claire Thomas, Penn State University) for eye-specific knockdown of RNAi lines. Ubiquitous knockdown experiments were performed using the w;da-GAL4;+ driver (Scott Selleck, Penn State University). For all experiments, we used appropriate GD (w1118, VDRC# 60000) or KK (y,w1118; P{attP,y+,w3`}, VDRC# 60100) lines as controls to compare against lines with RNAi knockdown of individual homologs. All fly lines were reared on standard cornmeal-yeast-dextrose Drosophila media at room temperature. All crosses were set and maintained at 25°C except for the eye knockdown experiments, which were maintained at 30°C.
Phenotypic analysis of adult wing images
Adult progeny were isolated from crosses between RNAi lines and bxMS1096-GAL4 driver shortly after eclosion, and kept at 25°C until day 2–5 (Fig 1). The progeny were then frozen at -80°C, and moved to -20°C prior to imaging. Approximately 20–25 progeny, both male and female, were collected for each RNAi line tested. The adult wings were plucked from frozen flies and mounted on a glass slide. The slides were covered with a coverslip and sealed using clear nail polish. Adult wing images were captured at 40X magnification using a Zeiss Discovery V20 stereoscope (Zeiss, Thornwood, NY, USA), with a ProgRes Speed XT Core 3 camera and CapturePro v.2.8.8 software (Jenoptik AG, Jena, Germany).
For each non-lethal RNAi line, we scored the adult wing images for five qualitative phenotypes, including wrinkled wing, discoloration, missing veins, ectopic veins, and bristle planar polarity defects, on a scale of 1 (no phenotype) to 5 (lethal) (Fig 3C). Lines showing severely wrinkled wings or lethality were scored as 4 (severe) or 5 (lethal) for all five phenotypes. We calculated the frequency of each phenotypic score (i.e. mild bristle polarity, moderate discoloration) across all of the wing images for each line (Fig 3A and 3B, S3 Data), and then performed k-means clustering of phenotypic frequencies for female RNAi lines to generate five clusters for overall wing phenotypes (Fig 2B, S3 Data). For quantitative analysis of wing phenotypes, we used the Fiji ImageJ software [95] to calculate the wing area using the Measure Area tool, and calculated the lengths of longitudinal veins L2, L3, L4, and L5 as well as the crossveins ACV and PCV by tracing individual veins using the Segmented Line tool (Fig 4A, S3 Data). We determined discordant homologs when multiple RNAi lines for the same homolog showed no wing phenotype versus any qualitative or quantitative wing phenotype, followed by discordance for small or large wing measurement phenotypes (S4 Data).
Phenotypic analysis of adult eye images
We crossed RNAi lines with GMR-GAL4 to achieve eye-specific knockdown of homologs of CNV and known neurodevelopmental genes. Adult female progeny aged 2–3 days were collected, immobilized by freezing at -80°C, and then moved to -20°C prior to imaging. Flies were mounted on Blu-tac (Bostik Inc, Wauwatosa, WI, USA) and imaged at 0.5X magnification using an Olympus BX53 compound microscope with LMPLan N 20X air objective using a DP73 c-mount camera (Olympus Corporation, Tokyo, Japan). CellSens Dimension software (Olympus Corporation, Tokyo, Japan) was used to capture the eye images, which were then stacked using the Zerene Stacker software (Zerene Systems LLC, Richland, WA, USA). All eye images presented in this study are maximum projections of approximately 20 consecutive optical z-sections, at a z-step size of 12.1μm. Finally, we used our computational method called Flynotyper (http://flynotyper.sourceforge.net) to quantify the degree of rough eye phenotypes present due to knockdown of homologs of CNV or neurodevelopmental genes [54]. Flynotyper scores for homologs of 16p11.2 and 3q29 genes, as well as select core neurodevelopmental genes, were derived from our previous studies [30,31,54].
Immunohistochemistry
Wing imaginal discs from third instar larvae were dissected in 1X PBS. The tissues were fixed using 4% paraformaldehyde and blocked using 1% bovine serum albumin (BSA). The wing discs were incubated with primary antibodies using appropriate dilutions overnight at 4°C. We used the following primary antibodies: mouse monoclonal anti-pH3 (S10) (1:100 dilutions, Cell Signaling 9706L), rabbit polyclonal anti-cleaved Drosophila dcp1 (Asp216) (1:100 dilutions, Cell Signaling 9578S), mouse monoclonal anti-wingless (1:200 dilutions, DSHB, 4D4), mouse monoclonal anti-patched (1:50 dilutions, DSHB, Drosophila Ptc/APA1), mouse monoclonal anti-engrailed (1:50 dilutions, DSHB, 4D9), and mouse monoclonal anti-delta (1:50 dilutions, DSHB, C594.9B). Following incubation with primary antibodies, the wing discs were washed and incubated with secondary antibodies at 1:200 dilution for approximately two hours at room temperature. We used the following secondary antibodies: Alexa Fluor 647 dye goat anti-mouse (A21235, Molecular Probes by Invitrogen/Life Technologies), Alexa Fluor 568 dye goat anti-rabbit (A11036, Molecular Probes by Invitrogen/Life Technologies), and Alexa Fluor 568 dye goat anti-mouse (A11031, Molecular Probes by Invitrogen/Life Technologies). All washes and antibody dilutions were made using 0.3% PBS with Triton-X.
Third instar larvae wing imaginal discs were mounted in Prolong Gold antifade reagent with DAPI (Thermo Fisher Scientific, P36930) for imaging using an Olympus Fluoview FV1000 laser scanning confocal microscope (Olympus America, Lake Success, NY). Images were acquired using FV10-ASW 2.1 software (Olympus, Waltham, MA, USA). Composite z-stack images were analyzed using the Fiji ImageJ software [95]. To calculate the number of pH3 positive cells within the wing pouch area of the wing discs, we used the AnalyzeParticles function in ImageJ, while manual counting was used to quantify dcp1-positive cells. We note that cell proliferation and apoptosis staining for NCBP2/Cbp20, DLG1/dlg1, BDH1/CG8888, and FBXO45/Fsn were previously published[31].
Statistical analysis
Significance for the wing area and vein length measurements, cell counts for proliferation and apoptosis, and Flynotyper scores were compared to appropriate GD or KK controls using one-tailed or two-tailed Mann-Whitney tests. P-values for each set of experiments were corrected for multiple testing using Benjamini-Hochberg correction. All statistical and clustering analysis was performed using R v.3.6.1 (R Center for Statistical Computing, Vienna, Austria). Details for the statistical tests performed for each dataset are provided in S11 Data.
Expression data analysis
We obtained tissue-specific expression data for fly homologs of CNV genes from the FlyAtlas Anatomical Microarray dataset [56]. Raw FPKM (fragments per kilobase of transcript per million reads) expression values for each tissue were categorized as follows: <10, no expression; 10–100, low expression; 100–500, moderate expression; 500–1000, high expression; and >1000, very high expression (S7 Data). The median expression among midgut, hindgut, Malpighian tube, and (for adult only) crop tissues was used to represent overall gut expression. We similarly obtained human tissue-specific expression data for CNV genes from the GTEx Consortium v.1.2 RNA-Seq datasets [58]. Median TPM (transcripts per million reads) expression values for each tissue were categorized as follows: <3, no expression; 3–10, low expression; 10–25, moderate expression; 25–100, high expression; and >100, very high expression (S7 Data). The median expression among all sub-types of brain and heart tissues was used to represent brain and heart expression, while the median expression among all colon, esophagus, small intestine, and stomach tissues was used to represent digestive tract expression. Tissue-specific preferential gene expression was determined if the expression of a gene within a particular tissue was greater than the third quartile of expression values for that gene across all tissues, plus 1.5 times the interquartile range. Venn diagrams were generated using the Venny webtool (http://bioinfogp.cnb.csic.es/tools/venny) (S4 Fig).
Network analysis
We obtained human tissue-specific gene interaction networks for brain, heart, and kidney tissues from the GIANT network database [74] within HumanBase (https://hb.flatironinstitute.org). These networks were built using a Bayesian classifier trained on tissue-specific gene co-expression datasets, which assigned posterior probabilities for interactions between pairs of genes within a particular tissue. We downloaded the “Top edge” version of each tissue-specific network, and extracted all gene pairs with posterior probabilities >0.2 to create networks containing the top ~0.5% tissue-specific interactions. Next, we identified the shortest paths in each network between human CNV genes whose fly homologs disrupted signaling pathways in the larval wing disc and human genes within each disrupted pathway, using the inverse of the posterior probabilities as weights for each interaction in the network. Gene sets from the human Notch (KEGG:map04330), Wnt (KEGG:map04310) and Hedgehog pathways (KEGG:map04340) were curated from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database [96]. Using the NetworkX Python package [97], we calculated the shortest distance between each CNV gene and pathway gene, and identified connecting genes that were within each of the shortest paths for the three tissue-specific networks. We further tested for enrichment of Gene Ontology (GO) terms (GO-Slim) among the connector genes using the PantherDB Gene List Analysis tool [98]. Lists of the shortest paths and connector genes in each tissue-specific network, as well as enriched GO terms for sets of connector genes, are provided in S9 Data. Gene networks were visualized in Cytoscape v.3.7.2 [99] using an edge-weighted spring embedded layout.
Mouse and human phenotypic data analysis
Phenotypic data for mouse models of CNV gene homologs, categorized using top-level Mammalian Phenotype Ontology terms, were obtained from the Mouse Genome Informatics (MGI) database [75] (S5 Data). Phenotypic data for human carriers of 10 pathogenic CNVs were obtained from the DECIPHER public database [9] (S1 Data). Clinical phenotypes for each CNV carrier were categorized by top-level Human Phenotype Ontology terms [100] using the Orange3 Bioinformatics software library (https://orange-bioinformatics.readthedocs.io), and the frequency of individuals carrying each top-level phenotype term was calculated for each CNV.
Code availability
All source code for data analysis in this manuscript, including scripts for k-means clustering of fly phenotypes, network connectivity of CNV and developmental pathway genes, and extraction of top-level human phenotype terms from DECIPHER clinical phenotype data, are available on the Girirajan lab GitHub page at https://github.com/girirajanlab/CNV_wing_project.
Supporting information
S1 Fig [pdf]
Phenotypic expression of CNV carriers across tissues.
S2 Fig [a]
Quantitative vein length phenotypes for select homologs of CNV and neurodevelopmental genes.
S3 Fig [fc]
Comparisons of eye-specific and wing-specific knockdowns for select homologs of CNV and neurodevelopmental genes.
S4 Fig [a]
Expression of homologs of CNV and neurodevelopmental genes in larval and adult tissues.
S5 Fig [pdf]
Additional homologs of CNV and neurodevelopmental genes show altered levels of cell proliferation and apoptosis.
S6 Fig [a]
Select female and male homologs of CNV and neurodevelopmental genes show altered levels of cell proliferation and apoptosis.
S7 Fig [a]
Additional homologs of genes within CNV regions interact with conserved signaling pathways to induce developmental phenotypes.
S8 Fig [a]
Tissue-specific network diagrams showing connectivity of human CNV genes with conserved signaling pathway genes.
S1 Data [xlsx]
Non-neuronal phenotypes of individuals carrying rare pathogenic CNVs in the DECIPHER database.
S2 Data [xlsx]
homologs of human CNV and neurodevelopmental genes, as determined using DIOPT v.7.1.
S3 Data [xlsx]
Qualitative and quantitative adult wing phenotypes for homologs of human CNV and neurodevelopmental genes.
S4 Data [xlsx]
Summary of adult wing qualitative and quantitative phenotypes for tested homologs.
S5 Data [mgi]
Phenotypes of mouse knockdown models for homologs of CNV genes.
S6 Data [fc]
Summary of eye-specific and wing-specific phenotypes for fly homologs.
S7 Data [gtex]
Tissue-specific expression of homologs and human CNV and neurodevelopmental genes.
S8 Data [xlsx]
Summary of immunostaining of the larval imaginal wing discs.
S9 Data [go]
Tissue-specific network connectivity for candidate CNV genes and signaling pathway genes.
S10 Data [xlsx]
List of stocks used for experiments, including VDRC stock numbers and genotypes.
S11 Data [xlsx]
Statistics for all experimental data.
Zdroje
1. Girirajan S, Campbell CD, Eichler EE. Human Copy Number Variation and Complex Genetic Disease. Annu Rev Genet. 2011;45: 203–226. doi: 10.1146/annurev-genet-102209-163544 21854229
2. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148: 1223–1241. doi: 10.1016/j.cell.2012.02.039 22424231
3. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43: 838–846. doi: 10.1038/ng.909 21841781
4. Zhang F, Gu W, Hurles ME, Lupski JR. Copy Number Variation in Human Health, Disease, and Evolution. Annu Rev Genomics Hum Genet. 2009;10: 451–481. doi: 10.1146/annurev.genom.9.081307.164217 19715442
5. Greenway SC, Pereira AC, Lin JC, Depalma SR, Israel SJ, Mesquita SM, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009;41: 931–935. doi: 10.1038/ng.415 19597493
6. Glessner JT, Bick AG, Ito K et al. Increased Frequency of De Novo Copy Number Variations in Congenital Heart Disease by Integrative Analysis of SNP Array and Exome Sequence Data. Circ Res. 2014;115: 884–896. doi: 10.1161/CIRCRESAHA.115.304458 25205790
7. Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M, Sampson MG, Hadley D, et al. Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet. 2012;91: 987–997. doi: 10.1016/j.ajhg.2012.10.007 23159250
8. Zahnleiter D, Uebe S, Ekici AB, Hoyer J, Wiesener A, Wieczorek D, et al. Rare copy number variants are a common cause of short stature. PLoS Genet. 2013;9: e1003365. doi: 10.1371/journal.pgen.1003365 23516380
9. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009;84: 524–533. doi: 10.1016/j.ajhg.2009.03.010 19344873
10. Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, Buysse K, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med. 2008;359: 1685–99. doi: 10.1056/NEJMoa0805384 18784092
11. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40: 1466–1471. doi: 10.1038/ng.279 19029900
12. Christiansen J, Dyck JD, Elyas BG, Lilley M, Bamforth JS, Hicks M, et al. Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res. 2004;94: 1429–35. doi: 10.1161/01.RES.0000130528.72330.5c 15117819
13. Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362: 239–52. doi: 10.1056/NEJMra0903074 20089974
14. Horev G, Ellegood J, Lerch JP, Son Y-EE, Muthuswamy L, Vogel H, et al. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad Sci. 2011;108: 17076–17081. doi: 10.1073/pnas.1114042108 21969575
15. Pucilowska J, Vithayathil J, Tavares EJ, Kelly C, Karlo JC, Landreth GE. The 16p11.2 Deletion Mouse Model of Autism Exhibits Altered Cortical Progenitor Proliferation and Brain Cytoarchitecture Linked to the ERK MAPK Pathway. J Neurosci. 2015;35: 3190–3200. doi: 10.1523/JNEUROSCI.4864-13.2015 25698753
16. Portmann T, Yang M, Mao R, Panagiotakos G, Ellegood J, Dolen G, et al. Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. Cell Rep. 2014;7: 1077–1092. doi: 10.1016/j.celrep.2014.03.036 24794428
17. Rutkowski TP, Purcell RH, Pollak RM, Grewenow SM, Gafford GM, Malone T, et al. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion. Mol Psychiatry. 2019. doi: 10.1038/s41380-019-0413-5 30976085
18. Baba M, Yokoyama K, Seiriki K, Naka Y, Matsumura K, Kondo M, et al. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome. Neuropsychopharmacology. 2019;44: 2125–2135. doi: 10.1038/s41386-019-0441-5 31216562
19. Arbogast T, Ouagazzal A-M, Chevalier C, Kopanitsa M, Afinowi N, Migliavacca E, et al. Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes. PLOS Genet. 2016;12: e1005709. doi: 10.1371/journal.pgen.1005709 26872257
20. Haller M, Au J, O’Neill M, Lamb DJ. 16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci. 2018;115: 201716092. doi: 10.1073/pnas.1716092115 29432158
21. Yadav S, Oses-Prieto JA, Peters CJ, Zhou J, Pleasure SJ, Burlingame AL, et al. TAOK2 Kinase Mediates PSD95 Stability and Dendritic Spine Maturation through Septin7 Phosphorylation. Neuron. 2017;93: 379–393. doi: 10.1016/j.neuron.2016.12.006 28065648
22. Richter M, Murtaza N, Scharrenberg R, White SH, Johanns O, Walker S, et al. Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling. Mol Psychiatry. 2019;24: 1329–1350. doi: 10.1038/s41380-018-0025-5 29467497
23. Golzio C, Willer J, Talkowski ME, Oh EC, Taniguchi Y, Jacquemont S, et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature. 2012;485: 363–367. doi: 10.1038/nature11091 22596160
24. Escamilla CO, Filonova I, Walker AK, Xuan ZX, Holehonnur R, Espinosa F, et al. Kctd13 deletion reduces synaptic transmission via increased RhoA. Nature. 2017;551: 227–231. doi: 10.1038/nature24470 29088697
25. Ip JPK, Nagakura I, Petravicz J, Li K, Wiemer EAC, Sur M. Major vault protein, a candidate gene in 16p11.2 microdeletion syndrome, is required for the homeostatic regulation of visual cortical plasticity. J Neurosci. 2018;38: 2017–2034. doi: 10.1523/JNEUROSCI.2034-17.2018 29540554
26. Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, et al. High-throughput discovery of novel developmental phenotypes. Nature. 2016;537: 508–514. doi: 10.1038/nature19356 27626380
27. Wangler MF, Yamamoto S, Bellen HJ. Fruit flies in biomedical research. Genetics. 2015;199: 639–653. doi: 10.1534/genetics.114.171785 25624315
28. Chien S. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 2002;30: 149–151. doi: 10.1093/nar/30.1.149 11752278
29. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;11: 1114–1125. doi: 10.1101/gr.169101 11381037
30. Iyer J, Singh MD, Jensen M, Patel P, Pizzo L, Huber E, et al. Pervasive genetic interactions modulate neurodevelopmental defects of the autism-associated 16p11.2 deletion in Drosophila melanogaster. Nat Commun. 2018;9: 2548. doi: 10.1038/s41467-018-04882-6 29959322
31. Singh MD, Jensen M, Lasser M, Huber E, Yusuff T, Pizzo L, et al. NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models. PLOS Genet. 2020;16: e1008590. doi: 10.1371/journal.pgen.1008590 32053595
32. Molnar C, Resnik-Docampo M, F. M, Martin M, F. C, de Celis JF. Signalling Pathways in Development and Human Disease: A Drosophila Wing Perspective. Human Genetic Diseases. InTech; 2011. doi: 10.5772/23858
33. Dworkin I, Gibson G. Epidermal growth factor receptor and transforming growth factor-β signaling contributes to variation for wing shape in Drosophila melanogaster. Genetics. 2006;173: 1417–1431. doi: 10.1534/genetics.105.053868 16648592
34. Testa ND, Dworkin I. The sex-limited effects of mutations in the EGFR and TGF-β signaling pathways on shape and size sexual dimorphism and allometry in the Drosophila wing. Dev Genes Evol. 2016;226: 159–171. doi: 10.1007/s00427-016-0534-7 27038022
35. Yan SJ, Gu Y, Li WX, Fleming RJ. Multiple signaling pathways and a selector protein sequentially regulate Drosophila wing development. Development. 2004;131: 285–298. doi: 10.1242/dev.00934 14701680
36. Strigini M, Cohen SM. A Hedgehog activity gradient contributes to AP axial patterning of the Drosophila wing. Development. 1997;124: 4697–4705. 9409685
37. Diaz de la Loza MC, Thompson BJ. Forces shaping the Drosophila wing. Mech Dev. 2017;144: 23–32. doi: 10.1016/j.mod.2016.10.003 27784612
38. Bier E. Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet. 2005;6: 9–23. doi: 10.1038/nrg1503 15630418
39. Wu Y, Bolduc FV, Bell K, Tully T, Fang Y, Sehgal A, et al. A Drosophila model for Angelman syndrome. Proc Natl Acad Sci U S A. 2008;105: 12399–12404. doi: 10.1073/pnas.0805291105 18701717
40. Yamamoto S, Jaiswal M, Charng WL, Gambin T, Karaca E, Mirzaa G, et al. A drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases. Cell. 2014;159: 200–214. doi: 10.1016/j.cell.2014.09.002 25259927
41. Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, et al. Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules. Am J Hum Genet. 2016;98: 149–164. doi: 10.1016/j.ajhg.2015.11.024 26748517
42. Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perrimon N, et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics. 2011;12: 357. doi: 10.1186/1471-2105-12-357 21880147
43. Capdevila J, Guerrero I. Targeted expression of the signaling molecule decapentaplegic induces pattern duplications and growth alterations in Drosophila wings. EMBO J. 1994;13: 4459–4468. doi: 10.1002/j.1460-2075.1994.tb06768.x 7925288
44. Lindström R, Lindholm P, Palgi M, Saarma M, Heino TI. In vivo screening reveals interactions between Drosophila Manf and genes involved in the mitochondria and the ubiquinone synthesis pathway. BMC Genet. 2017;18: 52. doi: 10.1186/s12863-017-0509-3 28578657
45. Nielsen J, Fejgin K, Sotty F, Nielsen V, Mørk A, Christoffersen CT, et al. A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission. Transl Psychiatry. 2017;7: 1261. doi: 10.1038/s41398-017-0011-8 29187755
46. Huang H, Potter CJ, Tao W, Li DM, Brogiolo W, Hafen E, et al. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development. 1999;126: 5365–5372. doi: 10.5167/uzh-627 10556061
47. Toyo-oka K, Mori D, Yano Y, Shiota M, Iwao H, Goto H, et al. Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation. J Cell Biol. 2008;180: 1133–1147. doi: 10.1083/jcb.200705148 18347064
48. Ohsugi M, Adachi K, Horai R, Kakuta S, Sudo K, Kotaki H, et al. Kid-Mediated Chromosome Compaction Ensures Proper Nuclear Envelope Formation. Cell. 2008;132: 771–782. doi: 10.1016/j.cell.2008.01.029 18329364
49. Kumar JP. Building an ommatidium one cell at a time. Dev Dyn. 2012;241: 136–149. doi: 10.1002/dvdy.23707 22174084
50. Nériec N, Desplan C. From the Eye to the Brain. Development of the Drosophila Visual System. Curr Top Dev Biol. 2016;116: 247–271. doi: 10.1016/bs.ctdb.2015.11.032 26970623
51. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, et al. Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science. 2001;293: 711–714. doi: 10.1126/science.1062382 11408621
52. Cukier HN, Perez AM, Collins AL, Zhou Z, Zoghbi HY, Botas J. Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet. 2008;4: e1000179. doi: 10.1371/journal.pgen.1000179 18773074
53. Bilen J, Bonini NM. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 2007;3: 1950–1964. doi: 10.1371/journal.pgen.0030177 17953484
54. Iyer J, Wang Q, Le T, Pizzo L, Grönke S, Ambegaokar SS, et al. Quantitative assessment of eye phenotypes for functional genetic studies using Drosophila melanogaster. G3 Genes, Genomes, Genet. 2016;6: 1427–1437. doi: 10.1534/g3.116.027060 26994292
55. Rosenberg MJ, Agarwala R, Bouffard G, Davis J, Fiermonte G, Hilliard MS, et al. Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat Genet. 2002;32: 175–179. doi: 10.1038/ng948 12185364
56. Chintapalli VR, Wang J, Dow JAT. Using FlyAtlas to identify better Drosophila melanogaster models of human disease. Nat Genet. 2007;39: 715–720. doi: 10.1038/ng2049 17534367
57. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68: 1327–1332. doi: 10.1086/320609 11359211
58. Ardlie KG, DeLuca DS, Segrè AV., Sullivan TJ, Young TR, Gelfand ET, et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;348: 648–660. doi: 10.1126/science.1262110 25954001
59. Ernst C. Proliferation and Differentiation Deficits are a Major Convergence Point for Neurodevelopmental Disorders. Trends Neurosci. 2016;39: 290–299. doi: 10.1016/j.tins.2016.03.001 27032601
60. Marchetto MC, Belinson H, Tian Y, Freitas BC, Fu C, Vadodaria KC, et al. Altered proliferation and networks in neural cells derived from idiopathic autistic individuals. Mol Psychiatry. 2017;22: 820–835. doi: 10.1038/mp.2016.95 27378147
61. Wei H, Alberts I, Li X. The apoptotic perspective of autism. Int J Dev Neurosci. 2014;36: 13–18. doi: 10.1016/j.ijdevneu.2014.04.004 24798024
62. Hartl TA, Scott MP. Wing tips: The wing disc as a platform for studying Hedgehog signaling. Methods. 2014;68: 199–206. doi: 10.1016/j.ymeth.2014.02.002 24556557
63. de Celis JF, García-Bellido A. Roles of the Notch gene in Drosophila wing morphogenesis. Mech Dev. 1994;46: 109–122. doi: 10.1016/0925-4773(94)90080-9 7918096
64. Raftery LA, Umulis DM. Regulation of BMP activity and range in Drosophila wing development. Curr Opin Cell Biol. 2012;24: 158–65. doi: 10.1016/j.ceb.2011.11.004 22152945
65. Diaz-Benjumea FJ, Cohen SM. Serrate signals through Notch to establish a Wingless-dependent organizer at the dorsal/ventral compartment boundary of the Drosophila wing. Development. 1995;121: 4215–4225. 8575321
66. Becam I, Milán M. A permissive role of Notch in maintaining the DV affinity boundary of the Drosophila wing. Dev Biol. 2008;322: 190–8. doi: 10.1016/j.ydbio.2008.07.028 18703041
67. Zecca M, Basler K, Struhl G. Sequential organizing activities of engrailed, hedgehog and decapentaplegic in the Drosophila wing. Development. 1995;121: 2265–2278. doi: 10.5167/uzh-1053 7671794
68. Tabata T, Kornberg TB. Hedgehog is a signaling protein with a key role in patterning Drosophila imaginal discs. Cell. 1994;76: 89–102. doi: 10.1016/0092-8674(94)90175-9 8287482
69. O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485: 246–250. doi: 10.1038/nature10989 22495309
70. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85: 841–851. doi: 10.1016/s0092-8674(00)81268-4 8681379
71. Johnson RL, Rothman AL, Xie J, Goodrich LV., Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272: 1668–1671. doi: 10.1126/science.272.5268.1668 8658145
72. Swarup S, Pradhan-Sundd T, Verheyen EM. Genome-wide identification of phospho-regulators of Wnt signaling in Drosophila. Dev. 2015;142: 1502–1515. doi: 10.1242/dev.116715 25852200
73. Six EM, Ndiaye D, Sauer G, Laâbi Y, Athman R, Cumano A, et al. The Notch ligand Delta1 recruits Dlg1 at cell-cell contacts and regulates cell migration. J Biol Chem. 2004;279: 55818–55826. doi: 10.1074/jbc.M408022200 15485825
74. Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, et al. Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 2015;47: 569–576. doi: 10.1038/ng.3259 25915600
75. Bult CJ, Blake JA, Smith CL, Kadin JA, Richardson JE, Mouse Genome Database Group. Mouse Genome Database (MGD) 2019. Nucleic Acids Res. 2019;47: D801–D806. doi: 10.1093/nar/gky1056 30407599
76. Zhou W, Zhang L, Guoxiang X, Mojsilovic-Petrovic J, Takamaya K, Sattler R, et al. GluR1 controls dendrite growth through its binding partner, SAP97. J Neurosci. 2008;28: 10220–10233. doi: 10.1523/JNEUROSCI.3434-08.2008 18842882
77. Iizuka-Kogo A, Ishidao T, Akiyama T, Senda T. Abnormal development of urogenital organs in Dlgh1-deficient mice. Development. 2007;134: 1799–1807. doi: 10.1242/dev.02830 17435047
78. Mahoney ZX, Sammut B, Xavier RJ, Cunningham J, Go G, Brim KL, et al. Discs-large homolog 1 regulates smooth muscle orientation in the mouse ureter. Proc Natl Acad Sci U S A. 2006;103: 19872–19877. doi: 10.1073/pnas.0609326103 17172448
79. Caruana G, Bernstein A. Craniofacial dysmorphogenesis including cleft palate in mice with an insertional mutation in the discs large gene. Mol Cell Biol. 2001;21: 1475–83. doi: 10.1128/MCB.21.5.1475-1483.2001 11238884
80. Chapman DL, Papaioannou VE. Three neural tubes in mouse embryos with mutations in the T-box gene Tbx6. Nature. 1998;391: 695–697. doi: 10.1038/35624 9490412
81. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: Tool for the unification of biology. Nat Genet. 2000;25: 25–29. doi: 10.1038/75556 10802651
82. Carbon S, Douglass E, Dunn N, Good B, Harris NL, Lewis SE, et al. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47: D330–D338. doi: 10.1093/nar/gky1055 30395331
83. Pabis M, Neufeld N, Shav-Tal Y, Neugebauer KM. Binding properties and dynamic localization of an alternative isoform of the cap-binding complex subunit CBP20. Nucleus. 2010;1: 412–421. doi: 10.4161/nucl.1.5.12839 21326824
84. Di Padova M, Bruno T, De Nicola F, Iezzi S, D’Angelo C, Gallo R, et al. Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter. J Biol Chem. 2003;278: 36496–504. doi: 10.1074/jbc.M306694200 12847090
85. Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N, et al. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell. 2002;2: 387–399. doi: 10.1016/S1535-6108(02)00182-4
86. Page G, Lödige I, Kögel D, Scheidtmann KH. AATF, a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis. FEBS Lett. 1999;462: 187–91. doi: 10.1016/s0014-5793(99)01529-x 10580117
87. Sumiyoshi E, Sugimoto A, Yamamoto M. Protein phosphatase 4 is required for centrosome maturation in mitosis and sperm meiosis in C. elegans. J Cell Sci. 2002;115: 1403–1410. 11896188
88. Jensen M, Girirajan S. An interaction-based model for neuropsychiatric features of copy-number variants. PLoS Genet. 2019;15: e1007879. doi: 10.1371/journal.pgen.1007879 30653500
89. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, et al. Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants. N Engl J Med. 2012;367: 1321–1331. doi: 10.1056/NEJMoa1200395 22970919
90. Coe BP, Girirajan S, Eichler EE. A genetic model for neurodevelopmental disease. Curr Opin Neurobiol. 2012;22: 829–836. doi: 10.1016/j.conb.2012.04.007 22560351
91. Nicholas AK, Swanson EA, Cox JJ, Karbani G, Malik S, Springell K, et al. The molecular landscape of ASPM mutations in primary microcephaly. J Med Genet. 2009;46: 249–253. doi: 10.1136/jmg.2008.062380 19028728
92. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 2001;410: 97–101. doi: 10.1038/35065105 11242049
93. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15: 70–73. doi: 10.1038/ng0197-70 8988171
94. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118: 401–15. 8223268
95. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012;9: 676–682. doi: 10.1038/nmeth.2019 22743772
96. Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47: D590–D595. doi: 10.1093/nar/gky962 30321428
97. Hagberg AA, Schult DA, Swart PJ. Exploring network structure, dynamics, and function using NetworkX. 7th Python in Science Conference (SciPy 2008). 2008. pp. 11–15.
98. Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version 11: Expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45: D183–D189. doi: 10.1093/nar/gkw1138 27899595
99. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13: 2498–2504. doi: 10.1101/gr.1239303 14597658
100. Köhler S, Carmody L, Vasilevsky N, Jacobsen JOB, Danis D, Gourdine JP, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47: D1018–D1027. doi: 10.1093/nar/gky1105 30476213
Článek vyšel v časopise
PLOS Genetics
2020 Číslo 6
- Antibiotika na nachlazení nezabírají! Jak můžeme zpomalit šíření rezistence?
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
Nejčtenější v tomto čísle
- AXR1 affects DNA methylation independently of its role in regulating meiotic crossover localization
- Osteocalcin promotes bone mineralization but is not a hormone
- Super-resolution imaging of RAD51 and DMC1 in DNA repair foci reveals dynamic distribution patterns in meiotic prophase
- Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis